Published in:
02-02-2023 | Radiotherapy | Original Paper
30 days postoperative outcome associated with vertical rectus abdominis myocutaneous (VRAM) flap reconstruction after pelvic surgery
Authors:
Thomas Vestermark Thomsen, M.D., Pernille Warming, M.D., Emir Hasanbegovic, M.D., Mikkel Børsen Rindom, M.D., ph.d., Lars Bjørn Stolle, M.D., Associate Professor, ph.d.
Published in:
European Journal of Plastic Surgery
|
Issue 5/2023
Login to get access
Abstract
Background
Following advanced malignancy in the pelvis, reconstruction of the defect arising from the primary surgical procedure is often required. This study compares patient demography and 30-days postoperative donor and recipient site complications in patients treated with a pedicled transpelvic Vertical Rectus Abdominis Myocutaneous (ptVRAM) flap.
Methods
Sixty-seven patients treated with a ptVRAM flap in 2015 and 2016 were included in the study. Patient demography, surgical indication, treatment, and surgical data were compared between patients with and without complications. Fisher’s exact test and the Mann-Whitney U test were used to compute p-values.
Results
This study shows a total donor and recipient site complication rate of 42% (n = 28) and the total 3-year survival was 73% (n = 49). Patients with a BMI ≥ 32 kg m-2 showed a significant correlation (p = 0.03) with postoperative complications. Smokers, patients with total vaginal reconstruction, and patients with one or more comorbidities were found to have a non-significant correlation with total postoperative complications (p = 0.13, p = 0.16, p = 0.17).
Conclusions
PtVRAM flaps can be used in the reconstruction of pelvic defects following advanced malignancies in patients previously treated with neoadjuvant chemo- or radiotherapy. Our results fall well within the findings of other studies and add to our knowledge of the surgical implications of treating perineal defects.
Level of Evidence: Level IV, risk / prognostic study.